A

ABIOMED Inc
F:AIO

Watchlist Manager
ABIOMED Inc
F:AIO
Watchlist
Price: 17.08 EUR -0.93% Market Closed
Market Cap: €776.5m

Wall St Price Targets

AIO Price Targets Summary
ABIOMED Inc

There are no price targets for AIO.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
ABIOMED Inc Competitors:
Price Targets
TXN
Texas Instruments Inc
-7% Downside
LEG
Leggett & Platt Inc
27% Upside
FDMT
4D Molecular Therapeutics Inc
196% Upside
URI
United Rentals Inc
11% Upside
H2A
H2APEX Group SCA
203% Upside
9688
Zai Lab Ltd
48% Upside

Revenue
Forecast

24% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
24% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is 14%.

Operating Income
Forecast

53% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
53% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 8 years, the compound annual growth rate for Operating Income has been 53%. The projected CAGR for the next 3 years is 17%.

Net Income
Forecast

44% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
44% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 8 years, the compound annual growth rate for Net Income has been 44%. The projected CAGR for the next 3 years is 32%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AIO's stock price target?
Not Available

AIO does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for ABIOMED Inc?
Projected CAGR
14%

Over the last 8 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is 14%.

What is the Operating Income forecast for ABIOMED Inc?
Projected CAGR
17%

Over the last 8 years, the compound annual growth rate for Operating Income has been 53%. The projected CAGR for the next 3 years is 17%.

What is the Net Income forecast for ABIOMED Inc?
Projected CAGR
32%

Over the last 8 years, the compound annual growth rate for Net Income has been 44%. The projected CAGR for the next 3 years is 32%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett